6875 fundamentals
An in-depth look to PHARMOSA BIOPHARM INC operating, investing, and financing activities
6875 free cash flow for Q3 24 is -133.42 M TWD. For 2023, 6875 free cash flow was -39.04 M TWD and operating cash flow was 42.42 M TWD.
Q3 '22
Q1 '23
Q3 '23
Q4 '23
Q1 '24
Q2 '24
Q3 '24
Cash from operating activities
Cash from investing activities
Cash from financing activities
Currency: TWD
Q3 '22
Q1 '23
Q3 '23
Q4 '23
Q1 '24
Q2 '24
Q3 '24
TTM